Allergan Licenses Rights to Medytox Candidates, in Up-to-$362M Deal
Posted By American Med Spa Association, Monday, June 25, 2018
![](https://www.americanmedspa.org/resource/resmgr/images/images_4/Screenshot_2018-06-25_13.18..png)
In return for the license, Allergan will pay Medytox $65 million up front, up to $116.6 million in potential payments tied to undisclosed development milestones, and another up to $180.5 million in potential payments tied to undisclosed commercialization milestones, plus royalties on product sales.
![](https://amspa.nyc3.digitaloceanspaces.com/images/advertisements/Nextech-Banner-Ad-07.15.24-08.15.24.jpg)